Perella Weinberg Partners has named Jeff Stute as a partner in its advisory business. Previously, Stute worked at JPMorgan where he was global co-head of healthcare investment banking.
NEW YORK – Perella Weinberg Partners (“PWP”) today announced that Jeff Stute has joined the Firm as a Partner in its Advisory business. Based in New York, he will work closely with the Firm’s global healthcare team, including Partners Chris O’Connor, Philippe McAuliffe, Nick Johnston, and Jason Forschler.
Mr. Stute is a veteran banker with approximately 25 years of investment banking experience. He joins PWP from JPMorgan, where he was Global Co-Head of Healthcare Investment Banking. Mr. Stute joined JPMorgan in 1994, primarily covering the company’s healthcare relationships. During his tenure, he also served as Head of Healthcare Investment Banking, North America from 2011 to 2016 and Co-Head of North American M&A from 2008 to 2011.
Peter A. Weinberg, a Founding Partner and Head of Advisory at PWP, said, “We are pleased to welcome Jeff to the Firm. Jeff is a highly-regarded banker with decades of experience advising healthcare clients. His addition deepens our coverage across the sector, including healthcare services and large cap pharmaceuticals, and will allow us to even better serve our clients as they evaluate ways to create value in an evolving healthcare landscape.”
Mr. Stute said, “I am excited to join Perella Weinberg’s leading healthcare team and to once again work with Chris, Philippe, Nick, and Jason. Their deep industry experience, partnership approach to client service and ability to provide distinct solutions to their clients’ strategic initiatives, distinguishes the group. I look forward to working in tandem with them to bring our expertise to an expanding global client base, while contributing to the growth of both the healthcare group and the firm more broadly.”
Perella Weinberg Partners has been actively advising healthcare clients globally. Some of the Firm’s recent assignments include advising:
Medtronic on its acquisition of Mazor Robotics for $1.6 billion;
Concordia International Corp. on its recapitalization transaction through the Canada Business Corporations Act;
Integrated DNA Technologies on its sale to Danaher;
Cascadian Therapeutics on its sale to Seattle Genetics, Inc. for $614 million;
Pamplona Capital on its acquisition of PAREXEL International for $5 billion;
Becton, Dickinson and Company on its acquisition of C.R. Bard, Inc. for $24 billion;
Cardinal Health on its acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion;
STADA in connection with the voluntary public tender offers by Bain Capital and Cinven valued at €5.3 billion; and
HeartWare International, Inc. on its sale to Medtronic for $1.1 billion.
About Perella Weinberg Partners
Perella Weinberg Partners is a leading global independent advisory firm, providing strategic and financial advice and asset management services to a broad client base, including corporations, institutions and governments. The Advisory business advises clients across a range of the most active industry sectors and international markets. Together with its affiliates, the Asset Management business has capital commitments and managed assets of approximately $13.7 billion. With approximately 650 employees, Perella Weinberg Partners maintains offices in New York, Houston, London, Austin, Calgary, Chicago, Denver, Dubai, Los Angeles, Paris, and San Francisco. For more information on Perella Weinberg Partners, please visit http://www.pwpartners.com.